About: A randomised phase II study of the efficacy, safety and cost-effectiveness of pegfilgrastim and filgrastim after autologous stem cell transplant for lymphoma and myeloma (PALM study)   Goto Sponge  NotDistinct  Permalink

An Entity of Type : owl:Thing, within Data Space : data.idref.fr associated with source document(s)

AttributesValues
Author
Bibliographic Citation
  • Sebban Catherine, Lefranc Anne, Perrier Lionel, Moreau Philippe, Espinouse Daniel, Schmidt A., Kammoun L., Ghesquières Hervé, Ferlay C., Bay Jacques-Olivier, Lissandre Séverine, Pérol David, Michallet M., Quittet Philippe. A randomised phase II study of the efficacy, safety and cost-effectiveness of pegfilgrastim and filgrastim after autologous stem cell transplant for lymphoma and myeloma (PALM study). European Journal of Cancer, Elsevier, 2012, 48 (5), pp. 713-720
  • Sebban Catherine, Lefranc Anne, Perrier Lionel, Moreau Philippe, Espinouse Daniel, Schmidt A., Kammoun L., Ghesquières Hervé, Ferlay C., Bay Jacques-Olivier, Lissandre Séverine, Pérol David, Michallet M., Quittet Philippe . A randomised phase II study of the efficacy, safety and cost-effectiveness of pegfilgrastim and filgrastim after autologous stem cell transplant for lymphoma and myeloma (PALM study) . European Journal of Cancer, 2012, 48 (5), pp . 713-720
Title
  • A randomised phase II study of the efficacy, safety and cost-effectiveness of pegfilgrastim and filgrastim after autologous stem cell transplant for lymphoma and myeloma (PALM study)
dc:date
  • 2012
Faceted Search & Find service v1.13.91 as of Aug 16 2018


Alternative Linked Data Documents: ODE     Content Formats:       RDF       ODATA       Microdata      About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data]
OpenLink Virtuoso version 07.20.3229 as of May 14 2019, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (70 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software